fda banning semaglutide Compounded Manufacturing Ban 🚨There's been a lot of

The Danish pharma giant announced in October that the oral form of semaglutide, the active ingredient in Ozempic and Wegovy, was shown to reduce the risk of major adverse heart events by 14% among people with Type 2 diabetes and cardiovascular disease and/or chronic kidney disease, compared with patients who were given a placebo

Nicotine patches, hormone replacement patches, and prescription pain patches are all FDA-approved examples that prove the mechanism works when the molecule is the right size and the delivery system is engineered correctly for it

That standard is not consistently being met

Use the coupon code "HAPPYSLOTH5" for an extra discount.

It should be noted, however, that oral semaglutide does require care upon administration to ensure proper absorption